Daiwa Securities Group Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Daiwa Securities Group Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$1.06 - $1.67 $4,091 - $6,446	-3,860 Reduced 6.13%	59,083 $69,000
Q4 2023 Jan 31, 2024	BUY	$1.26 - $1.79 $19,398 - $27,558	15,396 Added 32.38%	62,943 $106,000
Q2 2023 Jul 31, 2023	BUY	$1.14 - $1.95 $7,523 - $12,870	6,600 Added 16.12%	47,547 $88,000
Q1 2023 May 02, 2023	BUY	$1.2 - $2.19 $9,651 - $17,614	8,043 Added 24.44%	40,947 $54,000
Q4 2022 Feb 06, 2023	BUY	$1.63 - $3.52 $8,572 - $18,511	5,259 Added 19.02%	32,904 $56,000
Q3 2022 Nov 02, 2022	BUY	$0.73 - $3.74 $20,180 - $103,392	27,645 New	27,645 $86,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $11.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.